SAO PAULO, July 26 (Reuters) - China National Pharmaceutical Group Co Ltd (Sinopharm) has applied for emergency use authorization for its COVID-19 vaccine in Brazil, according to a statement from the country's health agency, Anvisa. (Reporting by Anthony Boadle Writing by Ana Mano Editing by Jonathan Oatis)
Brazil says China's Sinopharm asked for emergency use authorization for its COVID vaccine
![Reuters logo](/images/reuters.jpg)